Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Anne Hedegaard, PhD, Univeristy of Oxford, Oxford, UK, explains the development of a human cellular model, derived from induced pluripotent stem cells (iPSCs), which can be used to investigate inflammatory crosstalk among cells in the brain which are thought to be involved in the development of Alzheimer’s disease. This interview took place at the Alzheimer’s Research UK Conference 2022 in Brighton, UK.